These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15346097)

  • 21. Polycystic ovary syndrome and insulin resistance.
    Plosker SM
    Med Health R I; 2003 Jan; 86(1):12-5. PubMed ID: 12633015
    [No Abstract]   [Full Text] [Related]  

  • 22. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic management of type 2 diabetes: a review for dentistry.
    Little JW; Rhodus NL
    Gen Dent; 2007; 55(6):564-71; quiz 572-3, 599-600. PubMed ID: 18050585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hypertension in patients with diabetes.
    Sowers JR
    Arch Intern Med; 2004 Sep; 164(17):1850-7. PubMed ID: 15451759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes in the elderly and in women: cardiovascular risks.
    Sowers JR
    Cardiol Clin; 2004 Nov; 22(4):541-51, vi. PubMed ID: 15501622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
    Soares PR; Hueb WA; Lemos PA; Lopes N; Martinez EE; Cesar LA; Oliveira SA; Ramires JA
    Circulation; 2006 Jul; 114(1 Suppl):I420-4. PubMed ID: 16820611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An algorithm for the treatment of type 2 diabetes in Latin America.
    Chacra AR; Davidson JA; Diaz J; Escalante-Pulido M; Litwak LE; Mestman JH; More L; Violante RM
    Diabetes Obes Metab; 2005 Mar; 7(2):148-60. PubMed ID: 15715888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome].
    Cavallini C
    G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.
    Franjic B; Marwick TH
    J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
    [No Abstract]   [Full Text] [Related]  

  • 34. Reducing diabetes incidence through the inhibition of the renin-angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?
    Zanolla L; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):473-82. PubMed ID: 17568278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 diabetes mellitus in childhood: obesity and insulin resistance.
    Schwartz MS; Chadha A
    J Am Osteopath Assoc; 2008 Sep; 108(9):518-24. PubMed ID: 18806081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
    Malesker MA
    Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of modulating the renin-angiotensin system in preventing renal complications of hypertension.
    Rayner B
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):469-80. PubMed ID: 17186680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of pioglitazone on the drivers of cardiovascular risk in type 2 diabetes.
    Donnelly R
    Int J Clin Pract; 2007 Jul; 61(7):1160-9. PubMed ID: 17511791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.